Earnings Alerts

Hologic Inc (HOLX) Earnings Outperform Estimates: Analyzing the Surpass in Quarterly Results and Narrowed FY Adjusted EPS Forecast

  • Hologic has revised its FY Adjusted EPS Forecast. The new projection ranges from $4.02 to $4.12, an increase from the previous forecast of $3.97 to $4.12.
  • The estimated Adjusted EPS was $4.03.
  • The Adjusted EPS for the second quarter results stood at $1.03, surpassing the estimate of 98c.
  • Revenue for the second quarter amounted to $1.02 billion, outperforming the projected $1 billion.
  • Adjusted gross margin for the same quarter was 60.7%, slightly below the estimated 60.8%.
  • Adjusted net margin for the second quarter was 24%, exceeding the estimate of 23.2%.
  • Hologic’s performance ratings include 10 buys, 9 holds, and 0 sells.

Hologic Inc on Smartkarma

Analyst coverage of Hologic Inc on Smartkarma reveals a positive outlook from Baptista Research. In the report titled Hologic Inc: Fortifying Market Position Through Innovation & Strategic Acquisitions! – Major Drivers,” Hologic’s fiscal Q1 2024 results impressed with total revenue hitting $1.01 billion, surpassing company guidance. Despite fewer selling days compared to the previous year, the firm achieved strong organic revenue growth of 5.2%, which could have been even higher when adjusted for the reduced selling days.

Furthermore, Baptista Research‘s analysis in Hologic Inc.: Anticipating Continued Growth Across Divisions – What’s the Outlook for 2024? – Major Drivers,” showcases Hologic’s ability to exceed analyst expectations in Q4. The company reported total revenue of $945.3 million and non-GAAP earnings per share of $0.89, with a notable 16.7% organic revenue growth across all divisions. Hologic’s strategic capital allocation, including significant share repurchases in Q4 2023 and Q1 2024, further underscores its commitment to enhancing shareholder value.


A look at Hologic Inc Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Investment analysts using Smartkarma Smart Scores to assess Hologic Inc‘s long-term outlook see a mixed picture. With a Momentum score of 4 showing strong positive price trends, the company is displaying good performance in the market in the near term. This indicates potential for growth, supported by a solid Growth score of 3, suggesting that the company has room to expand its operations in the future. However, a low Dividend score of 1 may deter income-seeking investors looking for regular payouts from dividends.

Hologic Inc‘s Value score of 3 indicates that the company’s stock may be trading at a fair price relative to its fundamentals. The Resilience score of 3 highlights the company’s ability to weather economic downturns, adding a layer of stability to its long-term outlook. Overall, with a balanced mix of positive and concerning scores, investors may need to consider the company’s growth potential against its dividend payout in their investment decisions.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars